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Abstract
Background: The toxicity of snake venom varies over time in some species. The venom of newborn and small
juvenile snakes appears to be more potent than adults of the same species, and a bite from a snake that has not
fed recently, such as one that has just emerged from hibernation, is more dangerous than one that has recently
fed due to the larger volume of venom injected. Therefore, the potency of a snake’s venom is typically determined
using the LD50 or IC50 tests. In the present study, we evaluated the anti-tumor potential of snake venom from
Walterinnesia aegyptia (WEV) on the human breast carcinoma cell line MDA-MB-231, as well as its effect on the
normal mice peripheral blood mononuclear cells (PBMCs).
Results: This venom was used alone (WEV) or in combination with silica nanoparticles (WEV+NP). The IC50 values
of WEV alone and WEV+NP in the MDA-MB-231 cells were determined to be 50 ng/ml and 20 ng/ml, respectively.
Interestingly, at these concentrations, the venom did not affect the viability of normal human PBMCs. To
investigate the in vivo effects of this venom further, three groups of mice were used (15 mice in each group):
Group I was the control, Group II was subcutaneously injected with WEV, and Group III was injected with WEV+NP.
Using flow cytometry and western blot analysis, we found that the blood lymphocytes of WEV-injected mice
exhibited a significant increase in actin polymerization and cytoskeletal rearrangement in response to CXCL12
through the activation of AKT, NF-B and ERK. These lymphocytes also showed a significant increase in their
proliferative capacity in response to mitogen stimulation compared with those isolated from the control mice (P <
0.05). More importantly, in the WEV+NP-treated mice, the biological functions of normal lymphocytes were
significantly (P < 0.05) enhanced in comparison with those of WEV-treated mice.
Conclusion: Our data reveal the unique biological effects of WEV, and we demonstrated that its combination with
nanoparticles strongly enhanced these biological effects.
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Background
Cell proliferation is a basic biological process that
occurs continuously in higher organisms in response to
changes in their external and internal environments. In
the immune system, lymphocyte proliferation is an
important parameter indicating the status of the body’s
defenses [1]. Recent evidence from both animal and
human studies further supports the concept that lym-
phopenia can drive homeostatic proliferation and the
development of autoimmune disease [2]. The uncon-
trolled proliferation of cells leads to cancer metastasis;
therefore, several studies have focused on inhibiting the
proliferative capacity of cancer cells using various drugs.
Directional cell migration is an integral component of
cancer cell invasion during metastasis and involves
changes in the cytoskeleton and cell adhesion [3]. The
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multistep process that begins with the extension of
lamellipodia, cell-surface protrusions comprised of actin
filaments, which are anchored to the underlying substra-
tum by small, integrin-dependent focal adhesions. In
both normal and cancer cells, the polymerization of
actin pushes against the plasma membrane and provides
the force for forward movement. Within the cell body,
actin stress fibers generate contractile forces by pulling
against focal adhesions to induce retraction at the rear
of the cell membrane. The bundling of actin filaments
into stress fibers clusters and activates integrins, leading
to the formation of new focal adhesions [4]. In normal
cells, several transcription factors are activated following
cell stimulation, leading to cytoskeletal rearrangement
and proliferation. The extracellular-signal-regulated
kinase (ERK), NF-B and AKT signaling pathways are
major determinants in the control of diverse cellular
processes in normal lymphocytes such as proliferation,
survival, differentiation and motility. Mechanisms for
the inhibition of these pathways thus present targets for
cancer therapy [5]. Additionally, previous studies have
reported that the constitutive activation of NF-Bi n
human melanoma cells is linked to the activation of
AKT kinase, suggesting that the activation of AKT may
be an early marker of tumor progression in melanoma
[6] and that inhibitors of NF-B activation can block
the neoplastic transformation response [7,8].
Natural products are well recognized as sources for
drugs in several human ailments, including cancers.
D e s p i t et h ed i s c o v e r yo fm a n yd r u g so fn a t u r a lo r i g i n ,
the search for new anticancer agents remains necessary
to increase the number of available options and to iden-
tify less toxic and more effective drugs [9]. Snake venom
i sac o m p l e xm i x t u r eo fm a n ys u b s t a n c e sw i t haw i d e
spectrum of biological activities including toxins,
enzymes, growth factors, activators and inhibitors. Nat-
ural toxins, especially sub lethal doses of snake venom,
have shown the potential to reduce the size of solid
tumors and block angiogenesis [10]. Nanoparticles carry-
ing chemical therapeutics have shown great promise in
treating cancer patients. When loaded with anticancer
agents, nanoparticles can successfully increase drug con-
centrations in cancer tissues and act at the cellular level,
enhancing antitumor efficacy. The nanoparticles can be
endocytosed and/or phagocytosed by cells, with resulting
cell internalization of the encapsulated drug [11].
Few studies have investigated the effects of snake venom
in combination with nanoparticles on normal and cancer
cells. Therefore, in the present study, we investigated the
effects of Walterinnesia aegyptia v e n o m( W E V ) ,a l o n ea n d
in combination with silica nanoparticles (WEV+NP), on
the survival of a human breast carcinoma cell line (MDA-
MB-231) and human peripheral blood mononuclear cells
(PBMCs) in vitro and the in vivo effects of WEV and
WEV+NP on mouse lymphocytes.
Materials and methods
Preparation of Walterinnesia aegyptia venom
Walterinnesia aegyptia snakes were collected from the
central region of Saudi Arabia. The snakes were kept in
a serpentarium in the Zoology Department, College of
Science, King Saud University. The snakes were warmed
daily using a 100-watt lamp for nine hours, and water
was always available. The snakes were fed purpose-bred
mice every 10 to 14 days. The venom was milked from
adult snakes, lyophilized and reconstituted in 1X phos-
phate-buffered saline (PBS) prior to use.
Combination of snake venom with silica nanoparticles
A total of 25 mg of mesoporous silica nanoparticles was
added to a solution of 50 mg/ml venom in water. The
suspension was stirred for 2 hour; the evaporation of
water was prevented. The mesoporous silica nanoparti-
cles loaded with venom were recovered using high-speed
centrifugation and dried in a vacuum oven at 60°C.
Cell culture and reagents
Human MDA-MB-231 breast cancer cells were obtained
from Dr. Douaa Sayed at Assiut University, Egypt and
maintained in a culture medium consisting of MEM sup-
plemented with 10% heat-inactivated fetal bovine serum
(FBS, EuroClone, Life Science Division, Milan, Italy). The
anti-proliferative effect of WEV and WEV+NP on MDA-
MB-231 cells was determined using the 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) uptake method. The cells were plated at 1 × 10
6
cells/ml in 2 ml of culture medium in six-well Costar
plates (Corning, Corning, NY). The cells were treated with
different concentrations of WEV or WEV+NP for 1, 2, 6,
12, 24 or 48 h, and cytotoxicity was expressed as a relative
percentage of the OD values measured in the control and
WEV- and WEV+NP-treated cells. The experiments were
repeated using human peripheral blood mononuclear cells
(PBMCs). Morphological changes were observed after
exposure to WEV and WEV+NP using a phase-contrast
inverse microscope (Olympus, Japan).
Animals and lymphocyte isolation
Forty-five sexually mature 12-week-old male Swiss Web-
ster (SW) mice weighing 25-30 g each were obtained
from the Central Animal House of the Faculty of Phar-
macy at King Saud University. All animal procedures
were performed in accordance with the standards set
forth in the Guidelines for the Care and Use of Experi-
mental Animals by the Committee for the Purpose of
Control and Supervision of Experiments on Animals
(CPCSEA) and the National Institutes of Health (NIH).
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Committee of the Zoology Department, College of
Science, King Saud University. All animals were allowed
to acclimatize in metal cages inside a well-ventilated
room for 2 weeks prior to the experiment. The animals
were maintained under standard laboratory conditions (a
temperature of 23°C, a relative humidity of 60-70% and a
12-hour light/dark cycle) and were fed a diet of standard
commercial pellets and given water ad libitum.T h ea n i -
mals were divided into 3 experimental groups (n = 15/
group): group I was a control group that was subcuta-
neously injected with PBS, group II was subcutaneously
injected with WEV (50 ng/ml for 12 hrs) and group III
was subcutaneously injected with WEV+NP (20 ng/ml
for 12 hrs). Lymphocytes were isolated from the animals’
blood using Ficoll-Paque density gradients. The remaining
red blood cells were osmotically lysed using ACK buffer.
The cells were washed with phosphate-buffered saline
(PBS), counted using the Trypan blue exclusion test, and
cultured in R-10 culture medium (complete RPMI 1640
medium supplemented with 10% FCS, 2 mM L-glutamine,
100 IU/ml penicillin, 100 μg/ml streptomycin, 1 mM
sodium pyruvate, and 50 μM 2-mercaptoethanol).
F-actin polymerization assay
The isolated blood lymphocytes were cultured for two
hour in culture medium before the F-actin polymerization
test. Intracellular F-actin polymerization was assessed as
previously described [12]. Briefly, cells were harvested and
resuspended (4 × 10
6/ml) in HEPES-buffered RPMI 1640
at 37°C with or without CXCL12 (250 ng/ml). At the indi-
cated times, cell suspensions (100 μl) were added to 400 μl
of assay buffer containing 4 × 10
-7 M FITC-labeled phal-
loidin, 0.5 mg/ml L-a-lysophosphatidylcholine (both from
Sigma-Aldrich) and 4.5% formaldehyde in PBS. The fixed
cells were analyzed using flow cytometry, and the mean
fluorescence intensity (MFI) was determined for each sam-
ple. The percentage change in MFI was calculated for each
sample at each time point using the following formula:
(1-(MFI before the addition of CXCL12/MFI after the
addition of CXCL12) × 100.
Immunoblotting
Whole-cell lysates were prepared from lymphocytes that
were isolated from the control and WEV- and WEV+NP-
treated mice in RIPA buffer (20 mM Tris-HCl, pH 7.5,
120 mM NaCl, 1.0% Triton X100, 0.1% SDS, 1% sodium
deoxycholate, 10% glycerol, 1 mM EDTA and 1% pro-
tease inhibitor cocktail, Roche). Following centrifugation
at 16,000 × g at 4°C for 15 min, the protein concentra-
tions in the supernatants were determined using a pro-
tein assay kit (Bio-Rad, Hercules, CA). Equal amounts of
whole-cell protein (50 μg) were mixed with reducing
sample buffer (0.92 M Tris-HCl, pH 8.8, 1.5% SDS, 4%
glycerol, and 280 mM 2-ME) and separated using discon-
tinuous SDS-PAGE. Proteins were transferred onto nitro-
cellulose membranes using a Bio-Rad Trans-Blot
electrophoretic transfer device, and the membranes were
blocked for 1 h at room temperature with 1% BSA or 5%
skim milk dissolved in TBS (20 mM Tris-HCl, pH 7.4,
and 150 mM NaCl) supplemented with 0.1% Tween 20.
The membranes were then incubated in the same block-
ing buffer with anti-phospho-ERK, anti-phospho-AKT,
anti-phospho-IBa, anti-phospho-p38MAPK or anti-b-
actin antibodies (1:1,000; Cell Signaling Technology, Bev-
erly, MA). The blots were thoroughly rinsed and then
incubated with an HRP-labeled species-matched second-
ary antibody for another 1 h. Protein bands were detected
using enhanced chemiluminescence reagents (ECL,
SuperSignal West Pico Chemiluminescent Substrate, Per-
bio, Bezons, France), and the ECL signals were recorded
on Hyperfilm ECL. To quantify band intensities, the films
were scanned, saved as TIFF files and analyzed using
NIH ImageJ software.
CFSE proliferation assay
Isolated blood lymphocytes were harvested, washed twice
in PBS and stained with 0.63 mM carboxyfluorescein dia-
cetate succinimidyl ester (CFSE) (Molecular Probes,
E u g e n e ,O R )f o r8m i na tr o o mt e m p e r a t u r e .R e s i d u a l
CFSE was removed by washing three times in PBS, and
CFSE-labeled cells were seeded in 6-well plates, treated
with or without a mitogen cocktail and grown for 4 days
in cell culture medium. The CFSE fluorescence intensity
was measured using FACS analysis.
Statistical analysis
Data are expressed as the mean ± standard error of the
mean (SEM). Significant differences among groups were
analyzed using a one-way analysis of variance (for more
than two groups) followed by Tukey’s post-test using SPSS
software, version 17. Differences were considered statisti-
cally significant at P < 0.05. *P < 0.05, WEV-treated vs
control; #P < 0.05, WEV+NP-treated vs. control; +P <
0.05, WEV+NP-treated vs. WEV-treated groups.
Results
WEV affects the cell viability of breast cancer cells but
not normal cells
The effect of WEV on the viability of MDA-MB-231 cells
was assessed using the MTT uptake method. WEV inhib-
ited the growth of MDA-MB-231 cells in a concentra-
tion- and time-dependent manner (Figure 1A & 1B). The
combination of WEV with NP (WEV+NP) enhanced the
effect of WEV on the cancer cells. The maximal inhibi-
tory effects of WEV and WEV+NP on cell viability were
observed 12 hour after treatment with 50 ng/ml of WEV
alone or with 20 ng/ml of WEV+NP. The effects of WEV
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Page 3 of 10Figure 1 Time- and dose-dependent responses of cell viability after WEV and WEV+NP treatment. MDA-MB-231 cells were treated with
WEV (closed triangles) or WEV+NP (open circles) at concentrations of 1, 5, 10, 20, 50, 100 and 1,000 ng/ml (A) for different incubation times (1,
2, 6, 12, 24 and 48 hr) (B). (C) Human PBMCs were treated with WEV or WEV+NP at concentrations of 1, 5, 10, 20, 50, 100 and 1,000 ng/mL for
12 hr. The experiments were performed in triplicate, and the results are expressed as the mean percentage of viable cells ± SEM.
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eral blood mononuclear cells (PBMCs) were also tested
under the same conditions. Interestingly, the treatment
of PBMCs with 50 ng/ml of WEV alone or 20 ng/ml of
WEV+NP did not affect cell viability (Figure 1C). The
survival of PBMCs after treatment with up to 1 μg/ml of
WEV or WEV+NP was reduced by 25%. These experi-
ments were performed in triplicate, and the results are
expressed as the mean percentage of viable cells ± SEM.
These results were confirmed using a Trypan blue exclu-
sion test, which was used to determine cell viability and
numerical cell counts simultaneously in all the experi-
ments (data not shown).
WEV combined with NP enhances CXCL12-mediated actin
polymerization
To analyze their effect on the viability of normal cells
further, we investigated whether WEV alone or in combi-
nation with NP affected the normal functioning of lympho-
cytes in vivo. Three groups of mice (15 mice in each group)
were injected with saline (the control group), WEV (50 ng/
ml) or WEV+NP (20 ng/ml). Twelve hours post-injection,
their blood lymphocytes were isolated, and the degree of
CXCL12-mediated actin polymerization was determined.
Actin and microtubules provide a dynamic cellular frame-
work that orchestrates and ultimately controls cellular acti-
vation and cancer metastasis. Therefore, we monitored
actin polymerization after CXCL12 stimulation in PBMCs
isolated from the three groups of animals. The cells were
stimulated every 15 sec with CXCL12 (250 ng/ml), and the
degree of F-actin polymerization was determined using
flow cytometry. The degree of F-actin polymerization at
30 seconds in one representative experiment is shown as
the mean fluorescence intensity (MFI) as gray histograms
representing the lymphocytes from the three groups of ani-
mals (Figure 2A, B &2C). The data from 10 individual
mice in each group revealed that in the untreated control
group, the percentage of F-actin polymerization in the
PMBCs was 65 ± 4.6, 50 ± 5.6, 30 ± 3.2 and 7 ± 0.9 at 15,
30, 45 and 60 sec, respectively (gray squares) (Figure 2D).
The percentage of F-actin polymerization was significantly
increased in the PBMCs of the WEV-treated group (black
triangles) to 80 ± 4.3, 67 ± 3.5, 45 ± 3.3 and 9 ± 0.8 at 15,
30, 45 and 60 sec, respectively. Most importantly, the per-
centage of F-actin polymerization was significantly
increased in the PBMCs of the WEV-treated group (black
triangles) to 92 ± 3.9, 79 ± 4.8, 49 ± 2.9 and 15 ± 0.7 at 15,
30, 45 and 60 sec, respectively, (P < 0.05; n = 10).
WEV combined with NP increases CXCL12-mediated
signaling through AKT, NF-B and ERK but not p38MAPK
Lymphocytes are circulated continuously from the per-
ipheral to the secondary lymphoid organs to recognize
presented antigens (Ags), and this circulation is regulated
by chemokines and their receptors. In the secondary lym-
phoid organs, chemokines and antigen recognition by
lymphocytes mediate actin polymerization, cytoskeletal
rearrangement, cell proliferation and differentiation to
effector and Ag-specific memory cells. We therefore
monitored the effect of the CXCL12 chemokine on the
phosphorylation and activation of cytoplasmic transcrip-
tion factors that regulate the proliferation of PBMCs in
PBMCs isolated from the three groups of mice. Using
antibodies against pAKT, pIBa,p E R K ,p 3 8 M A P Ka n d
b-actin (as a control for the amount of protein loaded) in
western blot analyses, we normalized the levels of phos-
phorylated AKT, IBa,E R Ka n dp 3 8 M A P Kt ot h e
amount of total b-actin. In one representative experi-
ment, we observed that stimulation with CXCL12 for
5 minutes enhanced the phosphorylation of AKT, IBa,
ERK and p38 MAPK. Moreover, the CXCL12-mediated
phosphorylation of AKT, IBa and ERK, but not
P38MAPK, was clearly increased in PBMCs that
were isolated from WEV- and WEV+NP-treated mice
(Figure 3A). The results from 10 individual mice in each
group showed that the normalized levels of phosphory-
lated AKT, IBa and ERK induced by CXCL12 were sig-
nificantly increased in the WEV-treated group compared
with the control group (*P < 0.05). Moreover, the combi-
nation of WEV with NP significantly enhanced the effect
of WEV on the CXCL12-mediated phosphorylation of
AKT, IBa and ERK compared with the control (
#P<
0.05) and WEV-treated (
+P < 0.05) groups (Figure 3B). In
contrast, treatment with WEV or WEV+NP had no effect
on the CXCL12-mediated phosphorylation of P38MAPK.
WEV combined with NP enhances mitogen-induced cell
proliferation
Because treatment with WEV and WEV+NP enhanced
CXCL12-mediated signaling, which regulates cell prolif-
eration, we investigated whether the ability of PBMCs to
proliferate in response to mitogen, a phenomenon impor-
tant for the maintenance and survival of immune cells,
was altered by treatment with WEV or WEV+NP. We sti-
mulated PBMCs isolated from the three groups of mice
with mitogen and determined the proliferative ability of
lymphocytes after treatment with WEV or WEV+NP
using CFSE proliferation and flow cytometry analyses. In
one representative experiment, illustrated in Figure 4A, B
& 4C, we found that the percentage of spontaneously pro-
liferating PBMCs was markedly increased, rising from 3%
in the control group to 9% and 14% in the WEV- and
WEV+NP-treated groups, respectively. When the cells
were stimulated with mitogen, the percentage of prolifera-
tion was 41% in the control group versus 65% and 84% in
WEV- and WEV+NP-treated groups, respectively (Figure
4D, E &4F). To generate the results shown in Figure 4G,
we calculated the mitogen-induced specific proliferation of
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the percentage of un stimulated cells in the absence of
mitogen) from mitogen-induced proliferation (the percen-
tage of mitogen-stimulated cells). Our results revealed that
the proliferative capacity of PBMCs was significantly
increased, changing from 36 ± 4.2% in the control group
to 55 ± 5.2% and 72 ± 6.5% in the WEV- and WEV+NP-
treated groups, respectively (*P < 0.05, WEV vs. control;
#P < 0.05, WEV+NP vs. control;
+P < 0.05, WEV+NP vs.
WEV; n = 10).
Discussion
Although many studies have investigated the anti-tumor
and cytotoxic effects of snake venom on numerous types
of cancer cells [13,14], little is known regarding its effects
on breast cancer. Here, we investigated the effects of
snake venom on the MDA-MB-231 cell line. Proliferation
and survival are critically important for tumor growth
and metastatic spreading; therefore, proliferation and
survival constitute attractive targets for tumor therapy.
First, we assessed the ability of WEV to arrest the growth
of the MDA-MB-231 cell line, and we found that WEV
affected the cell viability of breast cancer cells without
inhibiting the viability of normal cells. The combination
of WEV with NP (WEV+NP) enhanced the effect of
WEV on the cancer cells. Our results agree with the
results of Park et al. (2009) [14], who attributed this
growth inhibition to apoptosis and cell cycle arrest. Inter-
estingly, at the same concentrations, the venom neither
alone nor in combination with nanoparticles induced the
in vitro growth arrest of normal PBMCs. We next investi-
gated how this venom might alter the biology of normal
lymphocytes in vivo. Actin cytoskeletal reorganization is
the primary mechanism of cell motility and is essential
Figure 2 WEV combined with NP enhanced CXCL12-mediated actin polymerization in mouse lymphocytes. Isolated blood lymphocytes
from the control (gray squares), WEV-treated (closed triangles) and WEV+NP-treated (open circles) mice were subjected to an F-actin
polymerization assay after CXCL12 stimulation, and the results were quantified using flow cytometry. A representative experiment showing the
degree of F-actin polymerization at 30 seconds is presented as gray histograms of cytometric data on lymphocytes from the control (A), WEV-
treated (B) and WEV+NP-treated (C) mice. The results are expressed as the percentage change in MFI (n = 6) ± SEM (D), as described in the
Materials and Methods section.
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Page 6 of 10Figure 3 Up-regulation of CXCL12-mediated PI3K/AKT, IBa and ERK signaling in lymphocytes after treatment with WEV or WEV+NP.
The phosphorylation of AKT, IBa, ERK and p38MAPK, which are the main signaling pathways downstream of CXCL12, was monitored in
lymphocytes isolated from the three groups of mice using western blot analysis. (A) Protein bands from one representative experiment of the
ten performed are shown for pAKT, pIBa, pERK, p38MAPK and b-actin. (B) The phosphorylation of AKT, IBa, ERK and p38MAPK was
normalized to the total b-actin levels. The results are expressed as the mean ± SEM of normalized phosphorylation values in control (gray bars),
WEV-treated (closed black bars) and WEV+NP-treated mice (hatched bars). *P < 0.05, WEV-treated vs. control; #P < 0.05, WEV+NP-treated vs.
control; +P < 0.05, WEV+NP-treated vs. WEV-treated groups.
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Page 7 of 10Figure 4 WEV combined with NP enhanced lymphocyte mitogen activation and proliferation. The ability of lymphocytes from the control,
WEV-treated and WEV+NP-treated mice to proliferate spontaneously or in response to mitogen stimulation was evaluated using CFSE assays and
flow cytometry. The isolated cells were labeled with CFSE, and the labeled cells were either left unstimulated (A, control; B, WEV; and C, WEV
+NP) or stimulated with mitogen (D, control; E, WEV; and F, WEV+NP). The analysis of CFSE staining was performed after gating on viable cells.
The percentage of proliferating cells (CFSE-lo) is indicated for each panel. One representative experiment of the ten is shown. (G) Data from 10
different experiments are expressed as the mean percentage of proliferating cells ± SEM for the control (gray bars), WEV-treated (closed black
bars) and WEV+NP-treated (hatched bars) mice. *P < 0.05, WEV-treated vs. control; #P < 0.05, WEV+NP-treated vs. control;
+P < 0.05, WEV+NP-
treated vs. WEV-treated groups.
Badr et al. Lipids in Health and Disease 2012, 11:27
http://www.lipidworld.com/content/11/1/27
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organs, which is regulated by chemokines [12,15]. There-
fore, we monitored actin polymerization in response to
CXCL12 stimulation and found that WEV combined
with NP enhanced CXCL12-mediated actin polymeriza-
tion. Similarly, Oliva et al. (2007) [16] suggested that
RGD-disintegrins isolated from snake venom were potent
anti-metastatic agents that contributed to the inhibition
of melanoma cell invasion through the involvement of
the actin cytoskeleton. The control of microfilament
actin remodeling thus represents a potential target for
the development of anticancer drugs [17]. It has been
reported that chemokines such as CCL20, CCL21 and
CXCL12 induce actin polymerization and chemotaxis in
B lymphocytes through the activation of PI3K/AKT, NF-
B, PLC, ERK and P38MAPK signaling [18,19]. Our data
revealed that WEV combined with NP increased
CXCL12-mediated signaling through AKT, NF-Ba n d
ERK but not through p38MAPK. A previous study found
that tungsten carbide-cobalt nanoparticles at 5 μg/cm
2
induced the production of reactive oxygen species (ROS)
that activated AKT and ERK signal pathways in murine
epidermal cells [20]. Additionally, in this study, WEV
combined with NP enhanced mitogen-induced lympho-
cyte proliferation. Similar observations have been
reported in the induction of endothelial cell proliferation,
migration, and angiogenesis by the interaction of aggre-
tin, a component of snake venom, with integrin a2b1,
leading to the activation of PI3K and AKT [21]. Taken
together, our data demonstrate a new effect of snake
venom in combination with nanoparticles on the biologi-
cal functioning of normal lymphocytes. However, the
growth arrest of the breast cancer cell line by WEV and
WEV+NP is more interesting. Therefore, in an ongoing
w o r k ,w ea r es t u d y i n gt h ee f f e c t so fW E Va n dW E V + N P
on the growth arrest of cancer cell lines in an attempt to
elucidate the molecular mechanism(s) by which this
venom affects cancer cells.
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